Capricor Therapeutics Inc (CAPR) Stock Soars on Drug Data

Biotech stock Capricor Therapeutics Inc (CAPR) is on pace for its best finish since August

Jun 16, 2016 at 2:52 PM
facebook twitter linkedin


Biotech stock Capricor Therapeutics Inc (NASDAQ:CAPR) is shooting higher today, picking up 14.5% at $4.75, thanks to upbeat data from the company's heart failure treatment. The shares were up as much as 30% earlier, and building off of Wednesday's 17% gain, they're now on pace for their highest close since August. However, this doesn't offer much solace to long-term shareholders. 

Specifically, CAPR has lost over half its value since hitting an annual high of $10.68 in March 2015. And things don't get any better if you expand the timeline, as the stock flirted with $50 in mid-2011. In other words, while CAPR has made a valiant rebound effort in 2016, it remains a long-term laggard.

Short sellers would like to see the shares resume this lackluster technical performance. Short sellers control more than eight days' worth of buying power on CAPR, based on its typical trading levels -- with short interest jumping over 7% in the last reporting period alone.

If these bears have any luck, Capricor Therapeutics Inc (NASDAQ:CAPR) stock could soon let off some steam, after its recent burst. At Wednesday's close, CAPR's 14-day Relative Strength Index (RSI) arrived at 68 -- just short of overbought territory. 

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

 

 

These investors are using the market's volatility to their advantage and scoring triple-digit gains on many of their trades.

Even in today's sideways bear market, this trading strategy has continued to provide consistency and profitability to a small group of investors. By using this approach, these traders are removing directional risk and still hitting triple-digit returns. If you want access to this strategy, and lower risk with higher returns sounds good to you, then don't wait another minute.

Join us now to receive our next trades the moment they come out!

 

Common mistakes options traders make
 


 


 
Special Offers from Schaeffer's Trading Partners